Search Results - Martinkevich, Irina

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Crude and Age-Adjusted Ph+/Bcr-Abl+ Chronic Myeloid Leukemia Incidence Rate in St. Petersburg and Leningrad Region Between 2006–2011

    Crude and Age-Adjusted Ph+/Bcr-Abl+ Chronic Myeloid Leukemia Incidence Rate in St. Petersburg and Leningrad Region Between 2006–2011 by Abdulkadyrov, Kudrat, Lomaia, Elza, Lazorko, Natalia, Shuvaev, Vasiliy, Abdulkadyrova, Alla, Martinkevich, Irina, Usacheva, Elena, Udalieva, Vera, Zotova, Irina, Machulaitene, Elena, Ilina, Natalia, Karyagina, Elena, Kholopova, Irina, Romanova, Ekaterina, Sbityakova, Eugenia, Shneider, Tatiana, Zaritskey, Andrey

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Busulfan Exposure Decrease CCyR Rate On Imatinib Therapy - Impact On Recent Pretreatment

    Busulfan Exposure Decrease CCyR Rate On Imatinib Therapy - Impact On Recent Pretreatment by Dyagil, Irina, Lomaia, Elza, Abdulkadirov, Kudrat, Goryunova, Elena, Lazorko, Natalia, Romanova, Ekaterina, Sbityakova, Eugenia, Abdulkadirova, Alla, Martinkevich, Irina, Udalieva, Vera, Usacheva, Elena, Zotova, Irina, Shuvaev, Vasiliy, Machulaitene, Elena, Poznyak, Ekaterina, Ivanova, Maria, Ilina, Natalia, Koryagina, Elena, Shneider, Tatiana, Stepanova, Svetlana, Dmitrenko, Irina, Babkina, Natalia, Perekhrestenko, Tatiana, Masliak, Zvenyslava, Zaritskey, Andrey

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    6 Year Experience of Treatment by Imatinib in CML CP Patientsin 6 Million Population Region of Russia(Saint-Petersburg and Leningrad region)with Impact On Time and Kind of Pretreatment

    6 Year Experience of Treatment by Imatinib in CML CP Patientsin 6 Million Population Region of Russia(Saint-Petersburg and Leningrad region)with Impact On Time and Kind of Pretreat... by Abdulkadirov, Kudrat, Lomaia, Elza, Shuvaev, Vasiliy, Abdulkadirova, Alla, Udalieva, Vera, Usacheva, Elena, Machulaitene, Elena, Zotova, Irina, Poznyak, Ekaterina, Koryagina, Elena, Ilina, Natalia, Shneider, Tatiana, Stepanova, Svetlana, Romanova, Ekaterina, Salamatova, Eugenia, Goryunova, Elena, Lazorko, Natalija, Martinkevich, Irina, Zaritskey, Andrey

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Experience in Second Line TKI Treatment in 6 Million Region of Russia (St-Petersburg and Leningrad region)

    Experience in Second Line TKI Treatment in 6 Million Region of Russia (St-Petersburg and Leningrad region) by Abdulkadirov, Kudrat, Lomaia, Elza, Abdulkadirova, Alla, Shuvaev, Vasiliy, Udalieva, Vera, Usacheva, Elena, Machulaitene, Elena, Zotova, Irina, Poznyak, Ekaterina, Koryagina, Elena, Ilina, Natalia, Shneider, Tatiana, Stepanova, Svetlana, Romanova, Ekaterina, Salamatova, Eugenia, Goryunova, Elena, Lazorko, Natalija, Martinkevich, Irina, Zaritskey, Andrey

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    b2a2 Type bcr-abl Transcript Chronic Myelogenous Leukemia (CML) Patients in Chronic Phase (CP) on Glivec Achieve Complete Cytogenetic Remission (CCyR) Earlier Than Those with b3a2

    b2a2 Type bcr-abl Transcript Chronic Myelogenous Leukemia (CML) Patients in Chronic Phase (CP) on Glivec Achieve Complete Cytogenetic Remission (CCyR) Earlier Than Those with b3a2 by Lomaia, Elza G., Martinkevich, Irina S., Ogorodnikova, Yulia S., Lyschov, Anton A., Bogdanov, Konstantin V., Zaritskey, Andrey Yu

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: